Found: 414
Select item for more details and to access through your institution.
Laboratory persistence and clinical progression of small monoclonal abnormalities.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Computed tomography assessment of bone lesions in patients with POEMS syndrome.
- Published in:
- European Radiology, 2015, v. 25, n. 2, p. 497, doi. 10.1007/s00330-014-3428-y
- By:
- Publication type:
- Article
POEMS syndrome: Update on diagnosis, risk‐stratification, and management.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 12, p. 1934, doi. 10.1002/ajh.27081
- By:
- Publication type:
- Article
Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1540, doi. 10.1002/ajh.27023
- By:
- Publication type:
- Article
Identifying signs and symptoms of AL amyloidosis in electronic health records using natural language processing, diagnosis codes, and manually abstracted registry data.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 9, p. E255, doi. 10.1002/ajh.27019
- By:
- Publication type:
- Article
A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL).
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 8, p. 1277, doi. 10.1002/ajh.26990
- By:
- Publication type:
- Article
Quality of life and symptoms among patients with relapsed/refractory AL amyloidosis treated with ixazomib‐dexamethasone versus physician's choice.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 5, p. 720, doi. 10.1002/ajh.26866
- By:
- Publication type:
- Article
Thrombosis in multiple myeloma: Risk estimation by induction regimen and association with overall survival.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 413, doi. 10.1002/ajh.26806
- By:
- Publication type:
- Article
Risk factors for severe infection and mortality In patients with COVID‐19 in patients with multiple myeloma and AL amyloidosis.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 1, p. 49, doi. 10.1002/ajh.26762
- By:
- Publication type:
- Article
Impact of achieving a complete response to initial therapy of multiple myeloma and predictors of subsequent outcome.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 267, doi. 10.1002/ajh.26439
- By:
- Publication type:
- Article
Prognostic significance of acquired 1q22 gain in multiple myeloma.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 1, p. 52, doi. 10.1002/ajh.26391
- By:
- Publication type:
- Article
Venetoclax for the treatment of multiple myeloma: Outcomes outside of clinical trials.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 9, p. 1131, doi. 10.1002/ajh.26269
- By:
- Publication type:
- Article
Assessment of fixed‐duration therapies for treatment‐naïve Waldenström macroglobulinemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 8, p. 945, doi. 10.1002/ajh.26210
- By:
- Publication type:
- Article
POEMS syndrome: 2021 Update on diagnosis, risk‐stratification, and management.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 7, p. 872, doi. 10.1002/ajh.26240
- By:
- Publication type:
- Article
Clinical correlates and prognostic impact of clonal hematopoiesis in multiple myeloma patients receiving post‐autologous stem cell transplantation lenalidomide maintenance therapy.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 5, p. E157, doi. 10.1002/ajh.26125
- By:
- Publication type:
- Article
Comparison of the current renal staging, progression and response criteria to predict renal survival in AL amyloidosis using a Mayo cohort.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 4, p. 446, doi. 10.1002/ajh.26092
- By:
- Publication type:
- Article
Outcomes with different administration schedules of bortezomib in bortezomib, lenalidomide and dexamethasone (VRd) as first‐line therapy in multiple myeloma.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 3, p. 330, doi. 10.1002/ajh.26074
- By:
- Publication type:
- Article
Outcomes of multiple myeloma patients with del 17p undergoing autologous stem cell transplantation.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 1, p. E35, doi. 10.1002/ajh.26023
- By:
- Publication type:
- Article
Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1553, doi. 10.1002/ajh.25992
- By:
- Publication type:
- Article
Characteristics of late transplant‐associated thrombotic microangiopathy in patients who underwent allogeneic hematopoietic stem cell transplantation.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 10, p. 1170, doi. 10.1002/ajh.25922
- By:
- Publication type:
- Article
Glycosylation of immunoglobulin light chains is highly prevalent in cold agglutinin disease.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. E222, doi. 10.1002/ajh.25843
- By:
- Publication type:
- Article
Utilizing multiparametric flow cytometry in the diagnosis of patients with primary plasma cell leukemia.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 6, p. 637, doi. 10.1002/ajh.25773
- By:
- Publication type:
- Article
Impact of minimal residual negativity using next generation flow cytometry on outcomes in light chain amyloidosis.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 5, p. 497, doi. 10.1002/ajh.25746
- By:
- Publication type:
- Article
Enhancing the R‐ISS classification of newly diagnosed multiple myeloma by quantifying circulating clonal plasma cells.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 3, p. 310, doi. 10.1002/ajh.25709
- By:
- Publication type:
- Article
Implications and outcomes of MRD‐negative multiple myeloma patients with immunofixation positivity.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 3, p. E60, doi. 10.1002/ajh.25702
- By:
- Publication type:
- Article
Hematopoietic score predicts outcomes in newly diagnosed multiple myeloma patients.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 1, p. 4, doi. 10.1002/ajh.25657
- By:
- Publication type:
- Article
Delayed neutrophil engraftment in patients receiving Daratumumab as part of their first induction regimen for multiple myeloma.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 1, p. E8, doi. 10.1002/ajh.25654
- By:
- Publication type:
- Article
Impact of consolidation therapy post autologous stem cell transplant in patients with light chain amyloidosis.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 10, p. 1066, doi. 10.1002/ajh.25572
- By:
- Publication type:
- Article
Monoclonal gammopathy‐associated thrombotic microangiopathy.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 10, p. E250, doi. 10.1002/ajh.25569
- By:
- Publication type:
- Article
Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosis.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 9, p. 1020, doi. 10.1002/ajh.25566
- By:
- Publication type:
- Article
POEMS Syndrome: 2019 Update on diagnosis, risk‐stratification, and management.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 7, p. 812, doi. 10.1002/ajh.25495
- By:
- Publication type:
- Article
Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapy.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 7, p. 751, doi. 10.1002/ajh.25481
- By:
- Publication type:
- Article
Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosis.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 5, p. E141, doi. 10.1002/ajh.25440
- By:
- Publication type:
- Article
Tetraploidy is associated with poor prognosis at diagnosis in multiple myeloma.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 5, p. E117, doi. 10.1002/ajh.25420
- By:
- Publication type:
- Article
Rapid assessment of hyperdiploidy in plasma cell disorders using a novel multi‐parametric flow cytometry method.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 4, p. 424, doi. 10.1002/ajh.25391
- By:
- Publication type:
- Article
Peripheral blood biomarkers of early immune reconstitution in newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 3, p. 306, doi. 10.1002/ajh.25365
- By:
- Publication type:
- Article
Utility and prognostic value of <sup>18</sup>F‐FDG positron emission tomography‐computed tomography scans in patients with newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 12, p. 1518, doi. 10.1002/ajh.25279
- By:
- Publication type:
- Article
Predictors of symptomatic hyperviscosity in Waldenström macroglobulinemia.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 11, p. 1384, doi. 10.1002/ajh.25254
- By:
- Publication type:
- Article
MASS‐FIX may allow identification of patients at risk for light chain amyloidosis before the onset of symptoms.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 11, p. E368, doi. 10.1002/ajh.25244
- By:
- Publication type:
- Article
Serum free light chain measurements to reduce 24‐h urine monitoring in patients with multiple myeloma with measurable urine monoclonal protein.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 10, p. 1207, doi. 10.1002/ajh.25215
- By:
- Publication type:
- Article
Time to plateau as a predictor of survival in newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 7, p. 889, doi. 10.1002/ajh.25113
- By:
- Publication type:
- Article
Efficacy of VDT PACE‐like regimens in treatment of relapsed/refractory multiple myeloma.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 2, p. 179, doi. 10.1002/ajh.24954
- By:
- Publication type:
- Article
Impact of involved free light chain (FLC) levels in patients achieving normal FLC ratio after initial therapy in light chain amyloidosis (AL).
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 1, p. 17, doi. 10.1002/ajh.24919
- By:
- Publication type:
- Article
Efficacy of daratumumab-based therapies in patients with relapsed, refractory multiple myeloma treated outside of clinical trials.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 11, p. 1146, doi. 10.1002/ajh.24883
- By:
- Publication type:
- Article
The prognostic significance of polyclonal bone marrow plasma cells in patients with relapsing multiple myeloma.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 9, p. E507, doi. 10.1002/ajh.24807
- By:
- Publication type:
- Article
The utility of MASS-FIX to detect and monitor monoclonal proteins in the clinic.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 8, p. 772, doi. 10.1002/ajh.24772
- By:
- Publication type:
- Article
IgM myeloma: A multicenter retrospective study of 134 patients.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 8, p. 746, doi. 10.1002/ajh.24753
- By:
- Publication type:
- Article
P OEMS syndrome: 2017 Update on diagnosis, risk stratification, and management.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 8, p. 814, doi. 10.1002/ajh.24802
- By:
- Publication type:
- Article
Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 7, p. 668, doi. 10.1002/ajh.24745
- By:
- Publication type:
- Article
Assessment of renal response with urinary exosomes in patients with AL amyloidosis: A proof of concept.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 6, p. 536, doi. 10.1002/ajh.24717
- By:
- Publication type:
- Article